Recent trends in the incidence and survival of stage I liver cancer: a surveillance, epidemiology, and end results analysis

Abstract

Background Improvements in screening and imaging technologies and treatment of liver disease have influenced the trend in diagnosis for stage I liver cancer. In this article, recent trends in age, incidence, tumour size, and survival of different stages of liver cancer are analysed. Methods Surveillance, Epidemiology, and end results data from the National Cancer Institute were used to analyse trends in age-adjusted incidence rate, mean tumour size at diagnosis, age at diagnosis, and 5-year survival probability for stage I liver cancer. Results Stage I cases of liver cancer increased most tremendously over the study period, with a greater increase from 2004 to 2012 following a smaller increase from 2012 to 2015. Moreover, the mean age of stage I liver cancer increased by 1.72 years from 2004 to 2015. The 5-year-overall survival for stage I liver cases worsened from 97.9% to 83.7% from 2004 to 2011, whereas the 10-year survival probability for stage I cases worsened from 97.3% in 2004 to 79.6% in 2006. Comparing with higher stage cases, stage I liver cancer were more likely to be females, be married, live in metro areas, receive chemotherapy, and carry medical insurance. Conclusions The incidence of stage I liver cancer has increased over the study period, with an increase in age of diagnosis, decrease in tumour size, and generally stable overall survival rate with slight decrease. These trends emphasized the importance of early detection of liver cancer and regular screening and better treatment for high-risk populations. RESEARCH HIGHLIGHTS Improvements in screening and imaging technologies and treatment of liver disease have influenced the trend in diagnosis for liver cancer. Stage I cases of liver cancer increased most tremendously over the study period, with a greater increase from 2004 to 2012 following a smaller increase from 2012 to 2015. These trends emphasized the importance of early detection of liver cancer and regular screening and better treatment for high-risk populations.

Hepatocellular Carcinoma Incidence and Mortality in the USA by Sex, Age, and Race: A Nationwide Analysis of Two Decades

“… 28 Previous data shows a significant increase in the incidence of early-stage HCC between 2004 and 2015. 29 Our study expands upon existing literature by revealing a decline in HCC incidence among younger men but not women, which was mostly attributable to early-stage tumors. Previous literature indicated that younger women are more inclined to undergo regular HCC surveillance, which may lead to a higher percentage of early-stage tumors being detected.…”

RNA m6A methylation regulators in liver cancer

“…Studies have shown that the overall 5-year survival rate of HCC is decreasing. Although the survival rate of early-stage HCC is still high, the prognosis of advanced HCC is not optimistic [ 16 ]. And when it comes to prognosis, the major obstacle to improving the prognosis of patients with HCC is that metastasis and recurrence occur in 60 to 80% of patients [ 17 ].…”